COREY BEAUSOLEIL: Open Payments
NPI 1467846147 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 10 payments from 8 companies in 2025. Trend: 2023 $868 · 2024 $882 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| Carlsmed, Inc. | 3 | $94 |
| SK Life Science, Inc. | 1 | $28 |
| EMD Serono, Inc. | 1 | $21 |
| UCB, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Tanabe Pharma America, Inc. | 1 | $14 |
Products named: aprevo, Fintepla, AUSTEDO XR, KISUNLA, NUCALA.
Industry payments across CA — which companies pay providers there.
